These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6132401)

  • 1. Promotion of chemically initiated hepatocarcinogenesis.
    de Gerlache J; Lans M; Taper H; Préat V; Roberfroid M
    Prog Clin Biol Res; 1982; 109():35-46. PubMed ID: 6132401
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a model to simulate the characteristics of rat liver tumor promotion by phenobarbital.
    Stevens FJ; Peraino C
    Carcinog Compr Surv; 1982; 7():105-9. PubMed ID: 7066914
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro measurement of resistance to phalloidin and gamma-glutamyltransferase of carcinogen-induced preneoplastic hepatocytes of rats.
    Sawada N; Furukawa K; Tsukada H
    J Natl Cancer Inst; 1982 Sep; 69(3):683-6. PubMed ID: 6125619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the development of rat liver preneoplastic lesions by verapamil and dexverapamil.
    Ghia M; Mereto E; Cavanna M; Brambilla G
    Anticancer Res; 1996; 16(4A):1739-41. PubMed ID: 8712693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation and promotion of liver tumorigenesis.
    Peraino C
    Natl Cancer Inst Monogr; 1981 Dec; (58):55-61. PubMed ID: 7341984
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W; Schaude G; Schwarz M; Tennekes H
    Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations of markers during hepatocarcinogenesis in rats.
    Lapis K; Ujhelyi E; Gyenes M; Jeney A
    IARC Sci Publ; 1984; (56):25-36. PubMed ID: 6152622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of varying the onset and duration of exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis.
    Peraino C; Fry RJ; Staffeldt E
    Cancer Res; 1977 Oct; 37(10):3623-7. PubMed ID: 908010
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects.
    Williams GM; Katayama S; Ohmori T
    Carcinogenesis; 1981; 2(11):1111-7. PubMed ID: 6119166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early histochemical markers of hepatocarcinogenesis].
    Vinarchuk MP; Bykorez AI
    Eksp Onkol; 1984; 6(1):11-6. PubMed ID: 6209085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal metaplasia as a common option of oval cells in relation to cholangiofibrosis in liver of rats exposed to 2-acetylaminofluorene.
    Tatematsu M; Kaku T; Medline A; Farber E
    Lab Invest; 1985 Apr; 52(4):354-62. PubMed ID: 2858600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats.
    Yager JD; Yager R
    Cancer Res; 1980 Oct; 40(10):3680-5. PubMed ID: 6108158
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of azo-dye hepatocarcinogenesis with dietary phenobarbital in rats.
    Kitagawa T; Sugano H
    Gan; 1977 Apr; 68(2):255-6. PubMed ID: 142681
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphological alterations and DNase deficiency in phenobarbital promotion of N-nitrosomorpholine initiated rat hepatocarcinogenesis.
    Taper HS; Lans M; de Gerlache J; Fort L; Roberfroid M
    Carcinogenesis; 1983; 4(2):231-4. PubMed ID: 6825212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenobarbital as a promoter in the initiation/selection process of experimental rat hepatocarcinogenesis.
    Lans M; de Gerlache J; Taper HS; Préat V; Roberfroid MB
    Carcinogenesis; 1983; 4(2):141-4. PubMed ID: 6825204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of different classes of modifying factors on experimental hepatic carcinogenesis].
    Gurkalo VK; Vlasov NN
    Vestn Akad Med Nauk SSSR; 1979; (12):31-5. PubMed ID: 229661
    [No Abstract]   [Full Text] [Related]  

  • 17. Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model.
    Chakraborty T; Chatterjee A; Saralaya MG; Dhachinamoorthi D; Chatterjee M
    Life Sci; 2006 May; 78(24):2839-51. PubMed ID: 16352317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of DDT on the hepatotoxic action of 2-acetylaminofluorene in Wistar rats].
    Syrowatka T; Jurek A; Nazarewicz T
    Rocz Panstw Zakl Hig; 1978; 29(1):57-64. PubMed ID: 653234
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological model of ED01 hepatocarcinogenesis.
    Travis CC; Zeng C; Nicholas J
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):19-29. PubMed ID: 8806866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of incomplete carcinogens and promoters in hepatocarcinogenesis.
    Pitot HC; Goldsworthy T; Moran S; Sirica AE; Weeks J
    Carcinog Compr Surv; 1982; 7():85-98. PubMed ID: 6802499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.